Stories

OHSU Knight Cancer Institute to create Community Melanoma Registry to aid outreach, research

May 13, 2014

The Knight Cancer Institute at Oregon Health & Science University is seeking melanoma survivors, their families and friends to join a new OHSU Community Melanoma Registry. It is open to anyone interested in attending community and education events and ...

Top researcher at Oregon Health & Science University named to pancreatic cancer Dream Team

April 09, 2014

Lisa M. Coussens, Ph.D., associate director of basic research for the Knight Cancer Institute at Oregon Health & Science University, was selected to serve as a principal investigator on an international pancreatic cancer Dream Team recently announced ...

Top researcher at Oregon Health & Science University named to pancreatic cancer Dream Team

April 09, 2014

Lisa M. Coussens, Ph.D., associate director of basic research for the Knight Cancer Institute at Oregon Health & Science University, was selected to serve as a principal investigator on an international pancreatic cancer Dream Team recently announced ...

Donors step up with $86 million in early giving to end cancer as we know it

March 12, 2014

Oregon Health & Science University (OHSU) gains significant momentum for Knight Cancer Challenge in first months of campaign Thousands of donors from 47 states, D.C. and Canada contribute Oregonians play leading role in early backing of vision, ...

Donors step up with $86 million in early giving to end cancer as we know it

March 12, 2014

Oregon Health & Science University (OHSU) gains significant momentum for Knight Cancer Challenge in first months of campaign Thousands of donors from 47 states, D.C. and Canada contribute Oregonians play leading role in early backing of vision, ...

International group of pediatric brain cancer researchers receives $300K toward a cure

January 07, 2014

An international consortium of researchers focused on identifying new molecularly targeted drugs to treat the most fatal form of childhood brain tumor, diffuse intrinsic pontine glioma, or DIPG, has been awarded nearly $300,000 by The Lyla Nsouli ...

International group of pediatric brain cancer researchers receives $300K toward a cure

January 07, 2014

An international consortium of researchers focused on identifying new molecularly targeted drugs to treat the most fatal form of childhood brain tumor, diffuse intrinsic pontine glioma, or DIPG, has been awarded nearly $300,000 by The Lyla Nsouli ...

Treatments in development for narcolepsy may reduce chemotherapy-induced fatigue

December 10, 2013

Chemotherapy found to disrupt neurons in the brain that promote wakefulness in a study conducted by researchers at the Knight Cancer Institute at Oregon Health & Science University Uncovering the cause of fatigue represents a turning point in ...

Taking on the Knights’ $1 billion cancer challenge

September 24, 2013

Focus on fundamental change in approach to detection based on new knowledge of cancer at molecular and genetic level Build on exclusive strengths in cancer research made possible in large part with donors' previous $100 million investment Leverage ...

Nike co-founder Phil Knight and wife Penny issue surprise $1 billion cancer challenge

September 21, 2013

OHSU leaders say ‘we’ll do it!’ Historic challenge pledge of $500 million electrifies cancer community gathered to celebrate the Knight Cancer Institute at Oregon Health & Science University. Philanthropists Phil and Penny Knight Friday pledged $500 ...

Stories

OHSU in the News